Alfavita Newsroom FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark. At the national level, FIMM was founded in 2007 as a joint research institute of the University of Helsinki (primary host), the Hospital District of Helsinki and Uusimaa, the National Institute for Health and Welfare, and VTT Technical Research Centre of Finland. In the beginning of 2017 FIMM joined the University of Helsinki’s new life science research centre, Helsinki Institute of Life Science HiLIFE, as an operational unit.
FIMM is currently seeking
Up to 6 Postdoctoral Researchers in Statistical and/or Translational Genomics for the new Centre of Excellence in Complex Disease Genetics for a fixed-term of two years with a possibility of extension for a third year
Description:
Revealing the molecular mechanisms underlying common complex diseases holds the promise of improved and targeted prediction, prevention, diagnosis and treatment. Building on unique resources and an extensive track record in disease genetic studies in Finland, the Academy of Finland Centre of Excellence in Complex Disease Genetics (CoECDG), hosted at the Institute for Molecular Medicine Finland (FIMM) at HiLIFE, aims to develop and apply a powerful, reliable and general strategy for comprehensive identification of risk and protective variants. The CoECDG will also develop and pilot strategies and lead national efforts to implement genomic findings into prevention and personalised treatment of common complex diseases.
The CoECDG is searching for outstanding candidates to work as postdocs in projects related to the CoE key focus areas. The CoECDG has 10 PIs and builds on Finnish unique strengths: Europe’s largest population isolate, large-scale genomic data, decades of nationwide health register follow -up, EHR with possibility for inbuilt automated decision-support systems – and focuses on genetic discovery and translation in three systemic diseases (coronary artery disease, diabetes and inflammatory bowel disease), neuropsychiatric disorders and addictions. The successful candidates will interact with research groups within CoECDG and with national and international collaborators and participate in collaborative research projects such as the FinnGen project. Much of the research at CoECDG will be done in collaboration with leading global genomics institutions. There is also a possibility for research visits to some of these, including the Broad Institute of MIT and Harvard.
In particular, we are looking for post docs for the following projects:
1) Role of genetics in pathways through major life-course health events
2) Building tools for prediction and prevention of key complex diseases
3) Building tools for personalised management of complex diseases
4) Genomics of pancreatitis
Qualification and experience: We are looking for future research leaders to work with large-scale genomic projects with potential to cutting edge research and to develop and pilot next generation approaches and tools for genomic medicine of complex diseases. The candidates are expected to hold a doctoral degree (or are expected to finish their degree soon), preferably in data science, clinical medicine, statistical genetics, genetic epidemiology, or in a related field.
Καταληκτική ημερομηνία: Δευτέρα 26 Μαρτίου 2018
Για να δείτε περισσότερες πληροφορίες πατήστε ΕΔΩ
Όλες οι σημαντικές και έκτακτες ειδήσεις σήμερα
ΕΛΜΕΠΑ: Το κορυφαίο πρόγραμμα Ειδικής Αγωγής στην Ελλάδα για διπλή μοριοδότηση
Το 1ο στην Ελλάδα Πρόγραμμα επιμόρφωσης Τεχνητής Νοημοσύνης για εκπαιδευτικούς με Πιστοποιητικό
ΑΣΕΠ: Η πιο Εύκολη Πιστοποίηση Αγγλικών για μόρια σε 2 ημέρες (δίνεις από το σπίτι σου με 95 ευρώ)
Παν.Πατρών: Μοριοδοτούμενο σεμινάριο ΕΙΔΙΚΗ ΑΓΩΓΗΣ με 65Є εγγραφή - έως 16/12
ΕΥΚΟΛΕΣ πιστοποιήσεις ΙΣΠΑΝΙΚΩΝ - ΙΤΑΛΙΚΩΝ - ΓΑΛΛΙΚΩΝ - ΓΕΡΜΑΝΙΚΩΝ για ΑΣΕΠ - Πάρτε τις ΑΜΕΣΑ
2ος Πανελλήνιος Γραπτός Διαγωνισμός ΑΣΕΠ: Τα 2 μαθήματα εξέτασης και η ύλη
